Abcam & Cancer Research UK join forces to accelerate cancer research

By Akshay Kedari  | Date: 2020-07-09

Abcam & Cancer Research UK join forces to accelerate cancer research

Cancer Research UK, one of the world's biggest independent funder of cancer research, has recently joined forces with Abcam plc, a leading developer of life science tools and reagents, to commercialize and develop novel custom antibodies to strengthen cancer research.

According to the terms of this partnership, Abcam would create custom protein-based reagents to targets that are recognized by researchers at Cancer Research UK. These antibodies would support the ongoing research and progress the understanding of cancer biology. Moreover, it would potentially be the basis for novel therapies as well as help generate new diagnostic tools.

Upon request, Abcam would deliver unique antibodies created during the terms of the agreement to researchers funded by Cancer Research UK for a pre-determined span of exclusivity in correspondence to that antibody. 

Meanwhile, Abcam’s co-location in key technology spots throughout the world and global supply capability would allow these innovative reagents to be easily available across wider diagnostic and research development community.

Speaking on the move, Tony Hickson, CBO, Cancer Research UK, said that the company is thrilled to collaborate with Abcam to develop tools that scientists require to help advance their understanding of cancer and to extend its access to biological reagents.

Additionally, Abcam’s “end-to-end” expertise and antibody development capabilities would support works of numerous researchers with antibody reagents that could be utilized from the initial stages of R&D right to the clinical trials.

As for Dr. John Baker, SVP of Product Portfolio Innovation, Abcam, the company is delighted to partner with Cancer Research UK to strengthen research by scientist and offer them easy access to validated and specific reagents, thereby helping them attain future breakthrough quickly.

Prior to this news, Abcam had made headlines when it announced that it has purchased assets of oncology product portfolio and gene editing platform from Applied StemCell, Inc. (ASC) for life science diagnostic and research markets. 
 

Source credit: https://www.abcam.com/index.html?pageconfig=news&rid=17091

About Author

Akshay Kedari     aeresearch.net

Akshay Kedari

A qualified computer engineering graduate, Akshay Kedari takes pride in having his way with words. Following his passion for content creation, he writes insightful pieces on aeresearch.net and a few other portals. Also endorsed with a short-term experience in web deve...

Read More >>

More News By Akshay Kedari

Instagram users can now delete their accounts on all Apple devices

Instagram users can now delete their accounts on all Apple devices

By Akshay Kedari

To comply with Apple’s App Store guidelines, popular social media platform Instagram has now added account deletion support to iOS devices. The iPhone maker's store policy notably instructs that all apps that allow users to create accounts ...

Tesla lays off 200 hourly workers as it closes its California office

Tesla lays off 200 hourly workers as it closes its California office

By Akshay Kedari

Tesla Inc. reportedly closed its San Mateo, California office to expedite cost-cutting and has let go nearly 200 workers who functioned on its autopilot driver-assistant system. Most of these employees were compensated on an hourly basis. Earlier ...

Around 2,900 Ford Lightning pickups recalled over software-linked issue

Around 2,900 Ford Lightning pickups recalled over software-linked issue

By Akshay Kedari

The recall covers 220 units of the electric pickup trucks in Canada and 2,666 units in the US. Ford has refused to accept any more orders and declared the EV sold out for 2022. Ford Motor Company has reportedly recalled the first batch of ...

Coca-Cola ranked the most powerful brand in U.S., as per the BSI score

Coca-Cola ranked the most powerful brand in U.S., as per the BSI score

By Akshay Kedari

The Coca-Cola Company, an American multinational beverage corporation, has reportedly secured a Brand Strength Index (BSI) score of 93.3 out of 100, making it the strongest brand in the USA, according to a TradingPlatforms.com analysis of the iconic ...

FDA to order Juul Labs to pull its e-cigarettes from the United States

FDA to order Juul Labs to pull its e-cigarettes from the United States

By Akshay Kedari

The U.S. FDA (Food and Drug Administration) is reportedly planning to instruct Juul Labs Inc. to stop supplying its e-cigarettes in the country. Shares of Altira, which owns a 35% stake in Juul Labs, fell to 8.5% after the latest development. For ...